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Natural peptide products often contain N-methylated
backbones, and such a modification plays a crucial
role in making natural peptides peptidase resistant
and membrane permeable. Here, we demonstrate
the ribosomal synthesis of N-methyl-peptides by
means of genetic code reprogramming. Two key
technologies, a ribozyme-based de novo tRNAacyla-
tion (flexizyme) system and an E. coli reconstituted
cell-free translation (PURE) system, were used in or-
der to reassign arbitrarily chosen codons toNa-meth-
ylated amino acids (Meaa). Using this combination,we
determined thegeneral structural requirement of ‘‘ac-
cessible’’ Meaa and demonstrated their multiple in-
corporations into the nascent peptide chain accord-
ing to the assignments made on mRNA, giving linear
and cyclic N-methyl-peptides in high purities. This
platform technology offers a convenient tool for the
construction of N-methyl-peptide libraries, poten-
tially leading to thediscovery of therapeutic peptides.INTRODUCTION
Natural peptide products isolated from various organisms often
contain N-methylated backbones (Billich and Zocher, 1990;
Hornbogen and Zocher, 2005). Such a modification of peptide
backbone alters the properties of the peptide bond, which con-
fers their conformational rigidity (Sagan et al., 2004). This modifi-
cation contributes to improvements in the biological properties of
natural peptides, such as target affinity, proteolytic stability, and/
or membrane permeability. Thus, Na-methylated amino acids
(Meaa) are invaluable components for the synthesis of peptide
libraries in screening for peptides with suitable drug-like proper-
ties for potential therapeutic use. The backboneN-methylation of
thesepeptidesaregenerally executedbyoneormoreof enzymes
in themultienzymeclusters, called nonribosomal peptide synthe-
tases (NRPSs) (Billich and Zocher, 1990; Hornbogen and Zocher,
2005; Sieber andMarahiel, 2005; Walsh et al., 2001). This type of
peptide synthesis machinery is known to be template indepen-
dent, in contrast to the mRNA template-dependent ribosomal
machinery. Unfortunately, their complexity demands an enor-
mous effort to manipulate the systems, therebymaking it difficult32 Chemistry & Biology 15, 32–42, January 2008 ª2008 Elsevier Ltdto generate desired peptide libraries (Baltz, 2006; Fischbach and
Walsh, 2006; Hahn and Stachelhaus, 2006).
On the other hand, the translation machinery expresses pep-
tides in an mRNA template-dependent manner, which makes
this system exceptionally versatile and useful for the synthesis
of peptides or proteins. Unlike NRPSs, the ordinary translation
system strictly incorporates 20 proteinogenic amino acids into
thenascentpeptidechain.However, anappropriatemanipulation
of the translation apparatus enables us to incorporate nonprotei-
nogenic amino acids into peptides (Hendrickson et al., 2004;
Hohsaka and Sisido, 2002; Link et al., 2003; Wang and Schultz,
2004). Aclassical example is thatwhenanonproteinogenicamino
acid is charged onto an orthogonal tRNACUA (the subscript base
sequence indicates the anticodon), this aminoacyl-tRNACUA
(aa-tRNACUA) is able to suppress UAG amber stop codon on
mRNA; thereby, the amino acid can be incorporated into the
nascent peptide at the designated site (Bain et al., 1989; Noren
et al., 1989). Despite encouraging results from a number of suc-
cessful examples for the incorporation of nonproteinogenic amino
acids with various nonnatural side chains, it has been known that
someMeaaare incorporated intoapeptidechainwithgoodormod-
est efficiencies, and some are not at all (Bain et al., 1991; Chung
et al., 1993; Ellman et al., 1992; Gilmore et al., 1999; Karginov
et al., 1997; Mendel et al., 1995; Murakami et al., 2006; Short
et al., 2000). To the best of our knowledge in the literature, only
threeMeaa,MeGly,MeAla,andMePhe,havebeensuccessfully incor-
porated into the nascent peptide chain by means of amber sup-
pression. Moreover, neither incorporation of multiple Meaa nor a
single Meaa with amino acids bearing noncanonical side chains
has been thus far reported.
More recently, a new concept of genetic code reprogramming
was introduced by Forster et al. and applied to the incorporation
of nonproteinogenic amino acids into peptides (Forster et al.,
2003). Genetic code reprogramming involves the reassignment
of codons from proteinogenic amino acids to nonproteinogenic
ones via multiple sense suppressions. Thus, this methodology
enables us to simultaneously incorporate multiple nonproteino-
genic amino acids into peptides, which represents a major ad-
vantage over the aforementioned amber suppression method
(Forster et al., 2003; Josephson et al., 2005; Murakami et al.,
2006; Ohta et al., 2007; Ohuchi et al., 2007; Tan et al., 2005).
In thecontext ofMeaausing the sensesuppressions, therewere
three examples in the literature (Frankel et al., 2003; Merryman
and Green, 2004; Tan et al., 2004). Merryman and Green have
reported that aa-tRNAs prepared by cognate aminoactyl-tRNAAll rights reserved
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Ribosomal Synthesis of N-Methyl-Peptidessynthetases (aaRSs)were converted toMeaa-tRNAsby the three-
step procedure, where the a-amino group was alkylated by
consecutive reductive amination with 2-nitrobenzaldehyde and
formaldehyde, and then the 2-nitrobenzyl group was depro-
tected by UV irradiation (Merryman and Green, 2004). These
Meaa-tRNAs derived from 20 proteinogenic amino acids were
surveyed for the synthesis of a dipeptide, fMet-Meaa, where
thin-layer chromatographic electrophoresis was mainly used
to discern the product of fMet-Meaa from fMet (also possibly
fMet-aa) and to determine the incorporation efficiency of each
Meaa in a semiquantitative manner. In the second example, Tan
and Cornish et al. prepared MeAla-tRNAAsnBGAC and
MePhe-
tRNAAsnBGAC by the chemoenzymatic aminoacylation procedure
(Hecht et al., 1978; Robertson et al., 1991) and performed their
single incorporation into a tripeptide (fMet-Xaa-Glu, where Xaa
represents Meaa) upon the sense suppression of the Val codon
(GUU) (Tanet al., 2004). Significantly, thisworkdetermined the in-
corporation efficiencies of these two Meaa into the peptide chain
in a quantitative manner and also confirmed the product peptide
by liquid chromatography based on its retention time by compar-
ison with that of the corresponding synthetic authentic sample.
Both examples above showed only a single incorporation ofFigure 1. Messenger RNA-Programmed Synthesis of
N-Methyl-Peptides by Genetic Code Reprogramming
(A) Synthesis of Na-methyl-aminoacyl-tRNA (Meaa-tRNA) by flexi-
zyme system. Flexizyme recognizes leaving group (LG: high-
lighted in pink) on the ester bond of Na-methyl-amino acid (Meaa)
substrate and conserved three bases on the 30-terminus of
tRNA, which allows for the aminoacylation of desired tRNA with
any Meaa. Na-methyl groups are highlighted in yellow.
(B) Ribosomal synthesis of N-methyl-peptide. Meaa-tRNAs bear-
ing various combinations of Meaa and anticodon are added to
the wPURE (withdrawn protein synthesis using recombinant ele-
ments) system for mRNA-programmed incorporation of Meaa
into peptides. The wPURE system is an E. coli reconstituted
cell-free translation system in which some components (amino
acids and aminoacyl-tRNA synthases) are withdrawn from the or-
dinary translation system to reassign multiple sense codons to
various Meaa.
(C) Reprogrammed genetic code table for the mRNA-pro-
grammed synthesis of N-methyl-peptides. Codons that are reas-
signed to various Meaa are shown in color letters. Initiation codon
(AUG) highlighted in gray is reassigned fromMet toNa-(a-chloroa-
cetyl)-Phe (ClAcPhe) for the ribosomal synthesis of cyclic N-methyl-
peptides.
Meaa into a di- or tripeptide backbone, and therefore
the concept of genetic code reprogramming has not
yet been fully explored for the synthesis of N-methyl-
peptides.
In the third example, Frankel and Roberts et al. have
shown polymerization of MePhe assigned to in repeti-
tion of two, five, or ten residues in an in vitro display
system (Frankel et al., 2003). This work represents,
to our knowledge, the first demonstration of consecu-
tive incorporations of a single type of Meaa into a pep-
tide stretch by using sense suppression. However,
because the polymerization of MePhe was only evi-
denced by observing the protease resistance of the
respective peptide, it still remains unknown to whatChemistry & Biologydegree of the contamination of natural amino acids in the
poly-MePhe chain occurred. In fact, the full-length peptide bear-
ing multiple MePhe was susceptible to protease to some extent,
suggesting that competing incorporations of likely Val or possi-
bly other proteinogenic amino acids occurred as Frankel et al.
discussed in their report (Frankel et al., 2003). Taken together, al-
though the above three examples clearly documented that the
sense-suppression method could be used for the incorporation
of Meaa, the proof-of-concept study on the genetic code reprog-
ramming, i.e., performing multiple incorporations of two or more
different Meaa with high fidelity control, remains to be demon-
strated.
We report here incorporation of multiple Meaa into the peptide
backbone with a nearly perfect control of sequences and lengths
by using the concept of genetic code reprogramming. To repro-
gram the genetic code, we used two technologies, flexizyme and
PURE (protein synthesis using recombinant elements) systems.
Flexizyme system is a ribozyme-based de novo tRNA acylation
system that is able to charge virtually any amino acids onto de-
sired tRNAs with any body and anticodon sequences (Figure 1A)
(Kourouklis et al., 2005; Murakami et al., 2003a, 2003b, 2006;
Ohuchi et al., 2007; Saito et al., 2001). PURE system is a15, 32–42, January 2008 ª2008 Elsevier Ltd All rights reserved 33
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Ribosomal Synthesis of N-Methyl-PeptidesFigure 2. Single Incorporations of Na-Methylated Amino Acids
(A) Sequences of mRNA and peptide. Flag in parentheses indicates the RNA sequence coding the Flag peptide (DYKDDDDK).
(B) Tricine-SDS-PAGE analysis of the expressed peptides labeled with [14C]-Asp detected by autoradiography. Lane 1, the wild-type peptide expressed in the
ordinary PURE system where ACC assigns Thr; lane 2, a negative control using wPURE system in the presence of uncharged tRNAAsn-E1GGU; lanes 3–25, ex-
pression of the peptide containing a single Meaa in the presence of designated Meaa-tRNAAsn-E1GGU prepared by the flexizyme system. Each expression level
relative to wild-type was determined by a mean score of triplicates. The amino acids giving over 30% and 10% expression levels relative to the wild-type are
highlighted in cyan and orange, respectively.34 Chemistry & Biology 15, 32–42, January 2008 ª2008 Elsevier Ltd All rights reserved
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Ribosomal Synthesis of N-Methyl-Peptidesreconstituted Escherichia coli cell-free translation system in
which transcription and translation are coupled (Shimizu et al.,
2001). The most important feature of this translation apparatus
is that some components, such as amino acids and amino-
acyl-tRNA synthases (aaRSs), can be withdrawn from the trans-
lation elements (Figure 1B). Bymeans of such awithdrawn PURE
system, namedwPURE, we are able to vacant certain codons at
our will. Combining these two systems enables us to readily
reassign the vacant codons to Meaa and express peptides as de-
signed on mRNA sequences according to the newly designated
genetic table (Figure 1C).
In this report, we initially screened Na-methylated proteino-
genic and nonproteinogenic amino acids to evaluate the effi-
ciency of their single incorporation into a peptide backbone.
Then, we investigated themRNA-programmed synthesis of pep-
tides containing multiple Meaa, achieving the compositions of
continuous stretches of up to ten Meaa residues. Finally, we in-
vestigated the synthesis of cyclic N-methyl-peptides closed by
a physiologically stable thioether bond, showing its potential
for the generation of in vivo compatible peptide libraries thera-
peutically targeting various proteins.
RESULTS
Single Incorporations of Na-Methylated Amino Acids
To investigate the incorporation of multiple Meaa into a peptide
backbone, various Na-methylated proteinogenic and nonprotei-
nogenic amino acids charged onto a tRNA by the flexizyme sys-
tem were comprehensively evaluated for the efficiency of their
single incorporation into a peptide backbone. As was discussed
earlier, Merryman and Green performed a similar experiment
with a dipeptide synthesis format (Merryman and Green, 2004).
In contrast, we here incorporated Meaa into a 12-mer model pep-
tide, thus involving the incorporation of Meaa into a specific site
followed by elongation and termination of peptide synthesis as
a format of normal peptide synthesis (Figure 2A, more details
are discussed below).
For this study, we chose 23 Meaa substrates, 19 of which were
derived from proteinogenic amino acids, and 4 of which were de-
rived fromnonproteinogenic aminoacids (FigureS1, see theSup-
plemental Data available with this article online). The flexizyme-
catalyzed aminoacylation efficiency for each Meaa was verified
by our standard protocol (Figure S2), showing that the majority
of Meaa could be charged onto tRNAwith over 30% yields. Three
amino acids, MeVal, MeIle, and MeAsn, showed less than 30%
yields. In the former two amino acids, their steric hindrance re-
sulted from the combination of the b-branched side chain and
the Na-methyl-amino group presumably made these particular
substrates much less reactive to flexizyme compared with other
Meaa. In the case of MeAsn, basedon our past experienceworking
on Asn-tRNA, its tRNA-adductmight be labile due to the intramo-
lecular attack of the amide side chain (Lee and Suga, 2001;
Murakami et al., 2006); thereby the yield might appear to be low
in PAGE analysis. However, we have previously observed thatChemistry & Biologysuch aa-tRNAs prepared in similar ranges of quality (Val-, Ile-,
and Asn-tRNAs in 13%–30% yield) could still be used for the in-
corporation into thenascent peptidechainwith satisfactory yields
(30%–70%) (Murakami et al., 2006). Thus, we pursued to survey
all Meaa-tRNAs for thesingle incorporation into themodelpeptide.
ThewPURE systemused in our surveywas composed of a lim-
ited member of amino acids and aaRSs. We designed an open-
reading frame (ORF) in mRNA (Figure 2A) that expresses a short
peptide consisting of fMet-Arg-Meaa-Arg followed by a Flag pep-
tide (DYKDDDDK; D, Asp; Y, Tyr; K, Lys). We selected a Thr
codon (ACC) to assign Meaa and an orthogonal tRNAAsn-E1GGU
(Ohta et al., 2007) for its suppression. When the model peptide
was expressed in the presence of uncharged tRNAAsn-E1GGU in
wPURE system, no product band appeared on tricine-SDS-
PAGE (Figure 2B, lane 2), suggesting that tRNAAsn-E1GGU could
act as an orthogonal tRNA inert against the endogenous aaRSs
added to the wPURE system.
We next tested the single incorporation of Meaa charged onto
tRNAAsn-E1GGU into the model peptide sequence. Eight out of
19 Meaa derived from proteinogenic amino acids were incorpo-
rated into the peptide with more than 30% efficiencies relative
to wild-type expression (Figure 2B, lanes 1 versus those high-
lighted in cyan). The incorporation of the designated Meaa was
also confirmed byMALDI-TOF analysis, giving the expectedmo-
lecular mass as a sole peak in all cases (Figure 2C). Moreover,
MeThr, MeGln, and MeTrp were modestly incorporated yet gave
the single desired product (Figures 2B and 2C, those highlighted
in orange). We called these Meaa molecules that could be incor-
porated into the peptide chain with more than 10% efficiencies
as ‘‘accessible’’ Meaa. Interestingly, all of these ‘‘accessible’’
Meaa shared similar structural features of their side chains; either
aromatic side chains (MePhe, MeTyr, MeHis, and MeTrp) or non-
charged and nonbulky side chains (MeGly, MeAla, MeSer, MeCys,
MeMet, MeThr, and MeGln).
It should be noted that our results were mostly consistent with
Merryman’s observations, with some contradictions (Merryman
and Green, 2004). In their experiments, MeVal, MeIle, and MeLeu
were ranked in the ‘‘efficient,’’ or what we referred to as the ‘‘ac-
cessible,’’ Meaa group. However, our experiments showed that
MeVal, MeIle, and MeLeu were grouped as rather ‘‘inaccessible’’
Meaa for incorporation (Figure 2B, lanes 5–7). The difference be-
tween the in vitro-transcribed tRNAAsn-E1 and the native cognate
tRNAs that Merryman et al. used as Meaa-carriers may have an
effect on their incorporation efficiencies (Dale and Uhlenbeck,
2005; LaRiviere et al., 2001). However, it should be noted that
in the Merryman’s TLC electrophoresis assay, the mobility of
these branched aliphatic Meaa were indistinguishable from that
of the cognate natural ones. Therefore, it was not clearly defined
if the observed product spot originated from fMet-Meaa or
fMet-aa. Because the reductive alkylation of some aa-tRNAs to
generate Meaa-tRNAs possibly left a small amount of unreacted
aa-tRNAs as Merryman et al. discussed (Merryman and Green,
2004), it could not be ruled out that such aa-tRNA contamitants
competed out Meaa-tRNAs for incorporation into the nascent(C) MALDI-TOF-MS spectra of the Flag-purified N-methyl-peptides. The calculated molecular mass (Calcd.) and observed molecular mass (Obsd.) for singly
charged species, [M+H]+1 are shown in each spectrum. In the spectrum of peptide with MeFni, an additional peak (asterisk) was detected since the additional
peak corresponds to Na-methyl-p-nitroso-Phe (Calcd. = 1674.72, Obsd. = 1675.45) generated by photodecomposition of NO2 to NO during the MALDI-TOF-
MS analysis (Ho and Chow, 1996).15, 32–42, January 2008 ª2008 Elsevier Ltd All rights reserved 35
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Ribosomal Synthesis of N-Methyl-Peptidespeptide chain. In contrast, in our studies, because the flexizyme
system ensures the purity of each Meaa-tRNA, i.e., no contami-
nation of aa-tRNA as confirmed by MALDI-TOF analysis (Fig-
ure 2C), we are able to avoid such issues and judge its intrinsic
incorporation efficiency more reliably and quantitatively. To this
end, we propose that MeVal, MeIle, and MeLeu are inaccessible
substrates due to the combination of bulkiness in the branched
side chain and the Na-methylated a-amino group.
Four Meaa derived from nonproteinogenic amino acids (Fig-
ure S1) were also incorporated into the corresponding peptide
chain (Figure 2B, lanes 21–25), each of which the MALDI-TOF
data was consistent with the expected molecular mass (Fig-
ure 2C). Again, the same trend for the incorporation efficiency
seemed to apply to these nonproteinogenic Meaa, where the
aromatic ones were incorporated more efficiently than the
aliphatic ones. All data taken together, we concluded that Meaa
having ‘‘aromatic’’ or ‘‘nonbulky and noncharged’’ side chainsFigure 3. Four Successive Incorporations ofMul-
tiple Na-Methylated Amino Acids
(A) Sequences of mRNA templates (m4-I–IV), tetra-
N-methyl-peptides (MeP4-I–IV), and the control wild-
type peptide (wt4-I). The kk-flag in parentheses indi-
cates the RNA sequence coding a KK-Flag peptide
(KKDYKDDDDK). Arabic number denotes the number
of N-methylated peptide bonds. The codons and amino
acids are colored according to the reprogrammed ge-
netic code table in Figure 1C.
(B) Tricine-SDS-PAGE analysis of the peptides ex-
pressed from m4-I labeled with [14C]-Asp detected by
autoradiography. Lane 1, the wild-type peptide ex-
pressed in the ordinary PURE system; lanes 2–4, nega-
tive controls in the presence of two of Meaa-tRNAAsn-E1
as shown; lane 5, in the presence of all three
Meaa-tRNAAsn-E1.
(C) MALDI-TOF-MS spectra of MeP4-I–IV. The calcu-
lated mass (Calcd.) and observed mass (Obsd.) are
shown in each spectrum.
were preferable for the incorporation into the
peptide backbone. This information is invalu-
able for us to select appropriate Meaa and de-
sign specific compositions of N-methylated
peptides or peptide libraries while avoiding
the risk of potential failure in the synthesis.
Four Successive Incorporations
of Multiple Na-Methylated Amino Acids
We next attempted the consecutive incorpo-
rations of multiple Meaa into the peptide back-
bone via genetic code reprogramming. Five
Meaa derived from proteinogenic amino acids
(MeSer, MePhe, MeTyr, MeCys, MeGly) and one
derived from a nonproteinogenic amino acid
(MeYme) were selected and assigned arbi-
trarily to six codons as shown in Figure 1C.
The flexizyme system was utilized to charge
the respective Meaa on tRNAAsn-E1 bearing
the anticodon that reads the assigned codon.
We also designed four mRNA templates con-36 Chemistry & Biology 15, 32–42, January 2008 ª2008 Elsevier Ltdtaining ORFs (Figure 3A, m4-I–IV) that express the correspond-
ing peptides comprised of three different Meaa in four successive
residues (Figure 3A, MeP4-I–IV). The C terminus of the respective
peptides was also designed to contain amodified Flag sequence
(KK-Flag = KKDYKDDDDK; D, Asp; Y, Tyr; K, Lys) to facilitate its
isolation as well as ionization upon MALDI-TOF analysis.
We first used m4-I to monitor the expression level of MeP4-I
by tricine-SDS-PAGE with a series of appropriate controls (Fig-
ure 3B). MeP4-I was expressed only when all designated
Meaa-tRNAAsn-E1s were present in the wPURE system (lanes 2–5),
suggesting that no competing background expression of undes-
ignatedpeptides occurred. The expression level of MeP4-Iwas an
approximately 20% relative to that of wild-type (wt4-I) expressed
in the ordinary PURE system (lanes 1 versus 5). Despite themod-
est expression level of MeP4-I, MALDI-TOF analysis of the Flag-
purified MeP4-I gave a single peak with the expected molecular
mass, indicating that the assigned codons on mRNA wereAll rights reserved
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tetra-N-methyl-peptide was expressed.
Likewise, MeP4-II–IV peptides were expressed at levels ap-
proximately 15%–20% of the corresponding wild-type peptides
(data not shown). Again, MALDI-TOF data of MeP4-II–IV peptides
were consistent with the expected mass (Figure 3C). Thus, all
mRNA ORFs tested in this study could be correctly translated
to the tetra-N-methyl-peptides according to the assigned co-
dons with high fidelities. This study represents, to our knowl-
edge, the first proof-of-concept experiment for the ribosomal
synthesis of N-methyl-peptides containing multiple kinds of
Meaa by the genetic code reprogramming.
Expression of Longer N-Methyl-Peptides
The achieved high fidelity control in the ribosomal synthesis of
the tetra-N-methyl-peptides encouraged us to attempt the ex-
pression of longer N-methyl-peptides. We designed four mRNA
templates that express N-methyl-peptides containing five, six,
eight, or ten consecutive N-methyl-peptide bonds (Figure 4A)
(m5/MeP5, m6/MeP6, m8/MeP8, m10/MeP10, respectively). These
peptides consisted of three Meaa in a repetition of the sequence
MeYme, MePhe, and MeSer for the corresponding length. To com-
pare the expression level of these N-methyl-peptides, the re-
spective wild-type peptides (wt5–10) were also expressed by
using the ordinary PURE system.
All mRNA templates successfully expressed the peptides in
the presence of the corresponding Meaa-tRNAAsn-E1s in wPURE
system (Figure 4B, gel figure). The absolute expression level for
each N-methyl-peptide, determined by its radioisotope intensity
originating from the incorporation of five [14C]-Asp residues in
the Flag peptide, gradually decreased with increasing peptide
length (Figure 4B, upper graph). However, since wild-type also
exhibited an inverse-correlation between expression level and
peptide length, the relative expression levels of N-methyl-pep-
tides to the corresponding wild-types remained in a similar range
(10%–20%), suggesting that the relative expression level was in-
dependent of length (Figure 4B, lower graph). Despite their mod-
est yields, the respective N-methyl-peptide had a single peak
with the expected molecular mass in MALDI-TOF analysis, indi-
cating that all peptides were expressed with high fidelities ac-
cording to the corresponding mRNA templates assigned with
the reprogrammed genetic code (Figure 4C).
In conclusion, our work has clearly demonstrated up to ten
successive incorporations of Meaa into the peptide backbone
via genetic code reprogramming with high fidelity control of
both the peptide sequence and length. This technology offers
a new means for the sequence-controlled synthesis of peptides
containing multiple N-methyl-modifications on their backbone.
Synthesis of Cyclic N-Methylated Peptides
Closed by a Thioether Bond
With the above method in our hands, we next applied it to the
synthesis of cyclic peptides closed by a physiologically stable
thioether bond. The foundation of this peptide ring-closing
method has been established during the course of our studies
on initiation reprogramming (Goto et al., 2008). Briefly, we pre-
pared a wPURE system where Met was depleted so that the ini-
tiation codon became vacant. This vacant initiation codon was
then filled with initiator tRNAfMetCUA charged with an arbitrarilyChemistry & Biologychosen proteinogenic or nonproteinogenic amino acid by the
flexizyme system, so that the translation starts from this newly
assigned initiator amino acid. When Na-(a-chloroacetyl)-amino
acid (Na-ClAc-aa) and Cys were assigned to the initiation and
elongation codons, respectively, the expressed full-length linear
peptide spontaneously cyclized via an intramolecular nucleo-
philic attack of the sulfhydryl group of the Cys side chain to the
N-terminal a-carbon of ClAc group, resulting in the formation
of a thioether bond. This technology has enabled us to synthe-
size various cyclic peptides with any sequences and ring sizes.
We here attempted to combine initiation reprogramming with
elongation reprogramming using Meaa, to enable us to devise
a flexible and reliable methodology for the mRNA-programmed
synthesis of cyclic N-methyl-peptides.
We designed three mRNA templates that express peptides
containing multiple N-methylated peptide bonds (Figure 5A,
mc-I–III). Six Meaa (MeAla, MeYme, MeTyr, MeGly, MeSer, MePhe)
and six proteinogenic amino acids (Phe, Lys, Tyr, Pro, Asp, Cys)
were chosen as the components of the cyclic N-methyl-peptides
in this study (Figures 5A and 5B, MecP-I–III). The respective pep-
tides MecP-I–III have two, three, and four N-methylated peptide
bonds, respectively, implanted by the newly assigned Meaa in
the codon table shown in Figure 1C. It should also be noted that
MecP-I and MecP-II contain Pro as a proteinogenic component
that also gives an additional secondary amide bond. These pep-
tides were expressed in the presence of initiator tRNAfMetCAU
charged with Na-ClAc-Phe and the corresponding Meaa-tRNAs
in the above wPURE system. The MALDI-TOF analysis of the
Flag-purified MecP-I–III showed that all peptides were spontane-
ously cyclized via a thioether bond upon completion of transla-
tion, giving only the programmed cyclic N-methyl-peptides (Fig-
ure 5C). This study indicates that this technology is applicable to
a wide array of cyclic peptides with multiple N-methyl-peptide
bonds.
DISCUSSION
In the first stage of our proof-of-concept studies, we evaluated
19 Meaa derived from proteinogenic amino acids and 4 Meaa
derived from nonproteinogenic amino acids, to determine the
accessible Meaa. This study has revealed that the ribosome is ac-
cessible to Meaa with aromatic or nonbulky and noncharged side
chains for the incorporation into the growing peptide. Most likely
the Na-methyl group added a steric bulkiness to the already
bulky structure of certain amino acids, thereby reducing their in-
corporation levels. It is not yet clear what is the most important
filter for the selection of accessible or inaccessible Meaa, but ei-
ther EF-Tu or ribosome (or possibly both) is very likely the deter-
minant(s) for their selection (Dale and Uhlenbeck, 2005). There-
fore, it is of importance in future experiments to define the
selection filter and engineer it to increase the tolerance toward
inaccessible Meaa (Dedkova et al., 2003, 2006).
In this study, we depleted both aaRSs and cognate amino
acids from the translation components in order to create vacant
codon boxes for Meaa assignments. In previous studies, the ge-
netic code reprogramming for nonproteinogenic amino acids
bearing nonstandard side chains could be achieved by using
a PURE system in which only proteinogenic amino acids, not
aaRSs, were withdrawn (Murakami et al., 2006). We found,15, 32–42, January 2008 ª2008 Elsevier Ltd All rights reserved 37
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(A) Sequences of mRNA templates (m5–10), control wild-type peptides (wt5–10), and peptides containing five, six, eight, or ten consecutive N-methyl-peptide
bonds (MeP5–10).
(B) Tricine-SDS-PAGE analysis of control wild-type peptides and N-methyl-peptides expressed from the respective mRNA. The peptides were labeled with
[14C]-Aspanddetectedbyautoradiography. Thewild-typepeptides (laneswith odd numbers)were expressed in the ordinaryPURE system,whileN-methyl-peptides
(lanes with even numbers) were expressed in the wPURE system containing MeYme-tRNAAsn-E1GGU,
MePhe-tRNAAsn-E1GAG, and
MeSer-tRNAAsn-E1GAA. Absolute
expression level of each peptide based on its observed radioisotope counts is shown in the upper graph, and relative expression level of each N-methyl-peptide
against the corresponding wild-type peptide is shown in the lower graph. Each expression level was determined by a mean score of triplicates.
(C) MALDI-TOF-MS spectra of MeP5–10. The calculated mass (Calcd.) and observed mass (Obsd.) are shown in each spectrum.38 Chemistry & Biology 15, 32–42, January 2008 ª2008 Elsevier Ltd All rights reserved
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Meaa often suffered from contaminations caused by the compet-
ing incorporations of the proteinogenic amino acids to the as-
signed sites (data not shown). This was because that even
though proteinogenic amino acids were supposedly depleted
from the translation components, the recombinant translation
factors and ribosome were often contaminated with small
amounts of proteinogenic amino acids; therefore, they were
charged onto the endogenous cognate tRNAs and readily com-
peted out Meaa for the incorporation at the reprogrammed codon
sites. Thus, it was critical to remove both aaRSs and proteino-
genic amino acids from the translation components in order to
repress the background incorporations of proteinogenic amino
acids into the peptide. Moreover, we used orthogonal tRNAs
as Meaa carriers aiming at eliminating potential mischarging
events with proteinogenic amino acids catalyzed by aaRSs leftChemistry & Biologyin the wPURE system. Combining all of these controlled ele-
ments in the wPURE system, we were able to wipe out undesir-
able backgrounds and thus succeeded in synthesizing
N-methyl-peptides as programmed by the mRNA.
Another key technology used in our proof-of-concept study is
the flexizyme system. This system enables us to readily prepare
a wide variety of Meaa-tRNAs with high purities, i.e., no contam-
ination of the competing aa-tRNAs, so that we can ensure Meaa
reassignments to the reprogrammed codons and thus determine
the accessible Meaa in a quantitative manner. This technology
has given us advantage over Merryman’s method involving re-
ductive alkylations on the precharged aa-tRNAs, where certain
amounts of competing aa-tRNAs could remain unreacted and
therefore contaminate the Meaa-tRNAs (Merryman and Green,
2004). As was discussed earlier, this might have led them to a
different conclusion from ours on the accessible Meaa.Figure 5. Synthesis of Cyclic N-Methyl-Peptides Closed by a Thioether Bond
(A) Sequences of mRNA templates (mc-I–III) and the precursor N-methyl-peptides (the linear version of MecP-I–III). The codons and amino acids are colored
according to reprogrammed genetic code table in Figure 1C.
(B) Structures of cyclic N-methyl-peptides. The locations of N-methyl groups on the peptide bond are shown in yellow.
(C) MALDI-TOF-MS spectra of cyclized MecP-I–III. The calculated mass (Calcd.) and observed mass (Obsd.) are shown in each spectrum.15, 32–42, January 2008 ª2008 Elsevier Ltd All rights reserved 39
Chemistry & Biology
Ribosomal Synthesis of N-Methyl-PeptidesIn a similar context, it would be difficult to perform Meaa as-
signments by the Szostak’s method, where endogenous aaRSs
or their mutants are used to mischarge nonproteinogenic amino
acids onto endogenous tRNAs (Hartman et al., 2006; Josephson
et al., 2005; Seebeck and Szostak, 2006). The major advantage
of the Szostak’s method is to in situ generate the mischarged
aa-tRNAs and thus express the nonnatural peptides by simply
adding nonproteinogenic amino acids to the wPURE system that
lacks the corresponding proteinogenic amino acids. This system
has been proven to be well suited for the incorporation of ‘‘highly
efficient’’ nonproteinogenic amino acids into the target peptide,
generally those structurally similar to proteinogenic amino acids
that can readily compete out the background incorporations of
amino acids originated by their contaminations (Seebeck and
Szostak, 2006). Szostak et al. have also surveyed the aminoacy-
lation ability of aaRSs toward Meaa, suggesting that MeLeu,
MeAsp, MeLys, MeHis, and MeTrp could be charged onto the cog-
nate tRNAs (Hartman et al., 2006). Unfortunately, among them
only MeHis and MeTrp were the ‘‘accessible’’ Meaa according to
our experimental results shown in Figure 2C. As was discussed
earlier, because of the intrinsic poor incorporation efficiency of
Meaa, such background incorporations would give impure prod-
ucts containing certain or occasionally significant amounts of
partially non-N-methylated peptides. In fact, by means of in
situ aaRS’s aminoacylation we found that MeHis could be incor-
porated to the designated site of the same model peptide with
competing incorporation of a smaller amount of His, whereas
no incorporation of MeTrp, i.e., only incorporation of the compet-
ing Trp, was observed (T.K. and H.S., unpublished data).
Under the optimal conditions for the wPURE and flexizyme
systems, we performed the mRNA-dependent synthesis of
N-methyl-peptides containing more than four successive Meaa
utilizing three different kinds of Meaa (Figures 3A and 4A). We
monitored the expression level of each N-methyl-peptide by tri-
cine-SDS-PAGE compared with the wild-type expression level
based on their radioisotope intensities originating from the incor-
poration of [14C]-Asp in the Flag peptide (Figures 3B and 4B).
Using this strategy, wewere able to directly compare the expres-
sion levels of the N-methyl-peptides in a quantitative manner.
Becausewechoseonly accessibleMeaa for thepolymerization,
we expected that the expression level would not be drastically
reduced compared to the single incorporation. However, the
expression of a tetra-N-methyl-peptide (MeP4-I) gave only 20%
of the wild-type expression level (Figure 3B, lanes 1 versus 5).
Moreover, when longer N-methyl-peptides (from 5-mer to
10-mer) were expressed, their relative expression levels did not
significantly change (Figure 4B).Wewonderedwhy the observed
relative expression level of the tetra-N-methyl-peptides drasti-
cally dropped from that observed for the mono-N-methyl-pep-
tide. To investigate this, we expressed mono-, di-, tri-, and
tetra-N-methyl-peptides (Figure S3) (MeP1-II, MeP2-II, MeP3-II,
and MeP4-II) and compared their expression levels with those of
the corresponding wild-type peptides (wt1-II, wt2-II, wt3-II, and
wt4-II). Interestingly, the absolute expression levels of wt3-II
and wt4-II were approximately three and four times higher, re-
spectively, than that of wt1-II. On the other hand, the absolute
expression levels of all N-methyl-peptides remained nearly the
same. Thus, it became apparent that the relative expression
levels of MeP3-II and MeP4-II to wt3-II and wt4-II appeared lower40 Chemistry & Biology 15, 32–42, January 2008 ª2008 Elsevier Ltdbecause the expression levels of wt3-II and wt4-II increased
from wt1-II, whereas the absolute expression level of all
N-methyl-peptides including5- to10-mersdidnot changesignifi-
cantly. Most importantly, MALDI-TOF analysis of the respective
N-methyl-peptide gave the corresponding single peak with
the correct molecular mass regardless of the length of the
N-methyl-peptide. These findings led us to attempt the synthesis
of cyclic-N-methyl-peptides.
In this application, we combined our technology for the Meaa
incorporation into peptides with the method previously devel-
oped for the initiation reprogramming with Na-ClAc-aa where
a linear peptide containing Cys is expressed to afford the corre-
sponding cyclic-peptide closed by a thioether bond between the
N-terminus and the sulfhydryl group of the Cys. Because the thi-
oether bond is nonreducible and thereby physiologically stable,
it has been implanted into some therapeutic peptides in order to
make them compatible for in vivo examination. Although such
cyclic peptides were previously generated by only solid-phase
chemistry, this method has enabled us to synthesize such cyclic
peptides by means of the translation apparatus. Thus, the com-
bination of the above two methods has offered us a platform
technology for the synthesis of cyclic N-methyl-peptides by de-
signing the corresponding mRNA templates. Remarkably, the
expressed full-length cyclic N-methyl-peptides were highly pure
in all three examples presented in this work. Thus, this tech-
nology is well suited for the preparation of libraries of cyclic
N-methyl-peptides. Particularly, when this is coupledwith in vitro
display systems, such as ribosome (Hanes and Pluckthun, 1997)
or mRNA displays (Nemoto et al., 1997; Roberts and Szostak,
1997), it becomes a very powerful means of screening large
libraries and selecting in vivo-compatible cyclic N-methyl-pep-
tides against therapeutic targets. Such experimental examples
are shortly up coming from our laboratory.
SIGNIFICANCE
Reprogramming the genetic code allows for the simulta-
neous incorporation of multiple amino acid monomers with
a wide variety of side chains into peptides through the ribo-
somal translation reaction. In this study, we achieved the
mRNA-directed synthesis of various sequences and lengths
of peptides containing multiple N-methylated amino acid
residues upon reprogramming the genetic code by using
the wPURE and flexizyme systems. Our demonstration
shows the potential of this technology that leads us to
a new strategy to construct libraries of linear and cyclic
N-methyl-peptides simply by designing mRNA sequence
libraries. Uponcombiningwith appropriate screening strate-
gies, this technology will yield a novel class of therapeutic
peptides with protease resistance and cell permeability.
EXPERIMENTAL PROCEDURES
Materials and Synthesis of Na-Methyl-Amino Acid Substrates
AllNa-methylated amino acids exceptNa-methyl-L-cysteine andNa-methyl-L-
methionine were purchased from Watanabe Chemical, Japan. Na-methyl-L-
cysteine was synthesized by the procedure reported before from L-cysteine
as a starting material (Park and Kim, 2002). Na-tBoc-Na-methyl-L-methionine
was synthesized by the procedure reported before fromNa-tBoc-L-methionine
as a starting material (Lee et al., 1990). Na-methylated amino acids with theAll rights reserved
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Ribosomal Synthesis of N-Methyl-Peptidesaromatic side-chain (MePhe, MeTyr, MeTrp, MeFni, and MeYme) were converted
to cyanomethyl esters (CMEs), and the others were converted to 3,5-dinitro-
benzyl esters (DBEs) by the procedure reported elsewhere (Murakami et al.,
2006).
Synthesis of Na-Methyl-Aminoacyl-tRNA
Aminoacylation reactions were generally performed as follows: 12.5 ml of
20 mM tRNA in 0.2 M HEPES-KOH (pH 7.5) was heated at 95C for 1 min
and cooled to room temperature over 5 min. Five microliters of 0.1 M MgCl2
and 2.5 ml of 0.1 mM dFx or 5 ml of 3 M MgCl2 and 2.5 ml of 0.1 mM eFx
were added to the solution. Five microliters of 25 mM Na-methylated amino
acid substrate (DBE or CME) in DMSO was then added to the mixture and in-
cubated on ice for 2–24 hr. For MeThr, MeTyr, MeFni, and MeYme, 5 ml of 200mM
substrate was used. The acylation reaction was quenched by addition of 150 ml
of 0.6 M sodium acetate (pH 5.0), and the tRNA was recovered by ethanol
precipitation. The pellet was rinsed twice with 70% ethanol with 0.1 M sodium
acetate (pH 5.0) and once with 70% ethanol.
Ribosomal Synthesis of Linear N-Methylated Peptides
and Wild-Type Peptides
The following conditions were used for the peptide synthesis without [14C]-
labeling. For the synthesis of N-methylated peptides (MeP4-I, MeP4-II, MeP4-III,
MeP4-IV, MeP5, MeP6, MeP8, MeP10, MeP1-II, MeP2-II, and MeP3-II), translation
reaction was carried out by using the wPURE system (see the Supplemental
Data) in the presence of 40 nM DNA template (one of the following templates:
m4-I, m4-II, m4-III, m4-IV, m5, m6, m8, m10, m1-II, m2-II, or m3-II), 0.1 mM of
the respective Meaa-tRNA(s), and 0.2 mM each of Met, Asp, Tyr, and Lys. For
the synthesis of wild-type peptides (wt4-I, wt5, wt6, wt8, wt10, wt1-II, wt2-II,
wt3-II, and wt4-II), translation reaction was carried out by using the ordinary
PURE system in the presence of 40 nM DNA template (one of the following
templates: m4-I, m5, m6, m8, m10, m1-II, m2-II, m3-II, or m4-II) and 0.2 mM
each of Met, Thr, Leu, Phe, Asp, Tyr, and Lys. The translation reactions were
assembled on ice and started by incubating at 37C for 3 hr. For the detection
of the peptides using autoradiography, see the section of tricine-SDS-PAGE
analysis.
Tricine-SDS-PAGE Analysis
For tricine-SDS-PAGE analysis, peptides were synthesized by using 50 mM
[14C]-Asp in the place of 0.2 mM Asp. The translation reaction (2.5 ml) was
stopped by the addition of 2.5 ml loading buffer consisting of 0.9 M Tris-HCl
(pH 8.5), 30% glycerol, and 8% SDS for loading to 15% tricine-SDS-PAGE.
Separation gel contained 15% acrylamide (acrylamide: bisacrylamide =
19:1), 1 M TrisHCl (pH 8.5), 0.1% SDS, and 13% Glycerol, while the stacking
gel contained 4% acrylamide (acrylamide: bisacrylamide = 29:1), 0.75 M
TrisHCl (pH 8.5), 0.075% SDS. The anode running buffer was 200 mM
TrisHCl (pH 8.9), while the cathode running buffer contains 100 mM Tris,
100 mM tricine, 0.1% SDS (the resulting buffer was approximately pH 8.3).
The products, labeled with [14C]-Asp in the C terminus FLAG peptide, were
quantified by autoradiography with an image analyzer, FLA-5100 (Fuji, Japan),
and the specific activity of [14C]-Asp.
Ribosomal Synthesis of Cyclic N-Methylated Peptides
For the synthesis of cyclic N-methylated peptide (MePc1, MePc2, or MePc3),
translation reaction was carried out by using the wPURE system with 40 nM
DNA template (mc1, mc2, or mc3) in the presence of 0.1 mM Na-ClAc-Phe-
tRNAfMetCAU, 0.1 mM of the respective
Meaa-tRNAs, and 0.2 mM each of
Met, Lys, Tyr, Pro, Asp, and Cys. The translation reactions were assembled
on ice and started by incubation at 37C for 3 hr.
MALDI-TOF-MS Analysis
The respective peptide was incubated in prewashed Flag-M2 agarose (Sigma)
foranhour.After theresinwaswashedwithTBS(50mMTris-HCl [pH8.0], 150mM
NaCl), the peptidewas elutedwith 0.2%TFA. Eluted peptidewas desaltedwith
C18 zip tips (Millipore) and eluted with 50% acetonitrile, 0.1% TFA solution
saturated with the matrix (R)-cyano-4-hydroxycinnamic acid. MALDI-TOF-
MS analysis was performed by using Autoflex TOF/TOF (Bruker Daltonics)
operated in the linear positive mode and externally calibrated with SubstanceChemistry & BiologyP (1348.66 Da), Bombesin (1620.88 Da), ACTH clip 1–17 (2094.46 Da), and
Somatostatin 28 (3149.61 Da) standards.
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures for RNA
synthesis, tRNA aminoacylation, and preparation of the translation systems
and are available at http://www.chembiol.com/cgi/content/full/15/1/32/DC1/.
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